Topic

Michigan

A collection of 518 issues

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Humana in Michigan: Prior Authorization Guide and Appeals Process

Answer Box: Getting Enhertu Covered by Humana in Michigan Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Humana Medicare Advantage plans due to its high cost (~$2,440 per 100mg vial) and specialized oncology use. To get coverage in Michigan: 1. Submit prior authorization via Humana's provider portal with

Getting Cometriq (Cabozantinib) Covered by Humana in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Cometriq Coverage To get Cometriq (cabozantinib) covered by Humana in Michigan: Your doctor must submit a prior authorization request through Humana's provider portal or by calling 800-555-2546, including diagnosis of metastatic medullary thyroid carcinoma, elevated calcitonin levels, and documentation that Cometriq capsules (not

How to Get Brensocatib (BRINSUPRI) Covered by UnitedHealthcare in Michigan: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting BRINSUPRI Covered in Michigan Brensocatib (BRINSUPRI) requires prior authorization through UnitedHealthcare's OptumRx with documented non-cystic fibrosis bronchiectasis, age 12+, ≥2 exacerbations yearly, and failed macrolide trial. Submit via the UnitedHealthcare Provider Portal or fax to 1-844-403-1027. If denied, you have 180 days for internal appeals,

How to Get Ferriprox (Deferiprone) Covered by Humana in Michigan: Prior Authorization Guide and Appeals Process

Answer Box: Getting Ferriprox (Deferiprone) Covered by Humana in Michigan Fastest path to approval: Submit prior authorization with documented ANC ≥1.5 x 10⁹/L, weekly monitoring plan, and evidence of transfusional iron overload (ferritin >1000 ng/mL). If denied, you have 65 days to appeal internally, then 127

How to Get Mavenclad (Cladribine Tablets) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Mavenclad Covered by Cigna in Michigan Cigna requires prior authorization for Mavenclad (cladribine tablets) with strict step therapy requirements - you must have failed two disease-modifying therapies (DMTs) or one high-efficacy agent like Ocrevus or Tysabri. Your neurologist submits the PA via Cigna's provider portal

How to Get Photrexa (Riboflavin Ophthalmic Solution) Covered by UnitedHealthcare in Michigan: Prior Authorization Timeline & Appeals Guide

Answer Box: Getting Photrexa Covered in Michigan Photrexa (riboflavin ophthalmic solution) requires prior authorization from UnitedHealthcare for corneal cross-linking in progressive keratoconus. The fastest path to approval: (1) Submit PA through the UHC Provider Portal with serial topography showing ≥1 diopter Kmax progression over 12 months, (2) Include pachymetry confirming

Myths vs. Facts: Getting Vyondys 53 (golodirsen) Covered by Blue Cross Blue Shield of Michigan – Complete 2025 Guide

Answer Box: Getting Vyondys 53 Covered by Blue Cross Blue Shield of Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Vyondys 53 (golodirsen), with genetic testing confirming DMD mutation amenable to exon 53 skipping from a CLIA-certified lab. Submit via the BCBSM Availity provider portal with complete

Do You Qualify for Evrysdi Coverage by Blue Cross Blue Shield of Michigan? Decision Tree & Next Steps

Answer Box: Your Fastest Path to Evrysdi Coverage Blue Cross Blue Shield of Michigan requires prior authorization for Evrysdi (risdiplam) with specific criteria: confirmed SMA diagnosis via genetic testing, baseline motor function assessment, and specialist involvement. Start today: Download the BCBSM-specific PA form, gather genetic test results and motor function

The Requirements Checklist to Get Brensocatib (BRINSUPRI) Covered by Cigna in Michigan

Answer Box: Getting Started in Michigan Cigna requires prior authorization for Brensocatib (BRINSUPRI) with step therapy through macrolide antibiotics. Your pulmonologist submits via CoverMyMeds or fax (866-873-8279) with CT scan confirming bronchiectasis, documented exacerbations (≥2/year for adults), and failed macrolide trials. Standard approval takes 5-10 business days. If denied,

Oxbryta (Voxelotor) Denied by UnitedHealthcare in Michigan? FDA Withdrawal & Alternative Coverage Options

Answer Box: Oxbryta Coverage Status & Next Steps Oxbryta (voxelotor) is no longer available in the US after Pfizer's voluntary withdrawal in September 2024 due to safety concerns. UnitedHealthcare automatically denies all Oxbryta claims since the drug lost FDA approval. If you're currently taking Oxbryta, work